ADAG Q2 2025 Earnings EPS Miss as ClinicalStage Biotech Focuses on Pipeline Advancement Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress PulteGroup PHM Q1 2026 Earnings Mixed Quarter as EPS Falls Slightly Short of Expectations Galectin Therapeutics Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Operational Progress SIM Q1 2023 Earnings EPS Misses Estimates by Wide Margin TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline